Immunologic aspects of otitis media

Current Allergy and Asthma Reports

Volumn 2, Issue 4, 2002, Pages 309-315

  Bernstein, Joel M ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

Eustachian Tube; Otitis Medium; Otitis Medium With Effusion; Outer Membrane Protein; Severe Combine Immune Deficiency

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G;

AUDITORY TUBE; HUMAN; IMMUNOLOGY; INFECTION; MICROBIOLOGY; MIDDLE EAR; NASOPHARYNX; NOSE MUCOSA; OTITIS MEDIA; PATHOPHYSIOLOGY; REVIEW; RHINITIS; T LYMPHOCYTE;

EAR, MIDDLE; EUSTACHIAN TUBE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INFECTION; NASAL MUCOSA; NASOPHARYNX; OTITIS MEDIA; RHINITIS; T-LYMPHOCYTES;

EID: 0036652817     PISSN: 15297322     EISSN: 15346315     Source Type: Journal    
DOI: 10.1007/s11882-002-0056-4     Document Type: Article

References (30)

1. Felding JU, Rasmussen JB, Lildholdt T: Gas composition of the normal and ventilated middle ear cavity. Scand J Clin Lab Invest Suppl 1987, 186:31–41. DOI: 10.3109/00365518709168152
2. Goycoolea MV, Paparella MM, Carpenter AM, Juhn SK: A longitudinal study of cellular changes in experimental otitis media. Otolaryngol Head Neck Surg 1979, 86:685–700.
3. Bernstein JM, Faden HF, Dryja DM, et al.: Micro-ecology of the nasopharyngeal bacterial flora in otitis-prone and nonotitis-prone children. In Recent Advances in Otitis Media. Edited by Lim DJ, Bluestone CD, Klein, JO, Nelson JD. Hamilton, Ontario: B. C. Decker Inc.; 1990, 1993:395–398.
4. Bernstein JM, Faden HF, Dryja DM, et al.: Micro-ecology of the nasopharyngeal bacterial flora in otitis-prone and non-otitis-prone children. Acta Otolaryngol Suppl (Stockh 1993, 112:1–7.)
5. Faden HF, Stanievich J, Brodsky L, et al.: Changes in the nasopharyngeal flora during otitis media of childhood. Pediatr Infect Dis J 1990, 9:623–626.
6. Faden H, Waz MJ, Bernstein JM, et al.: Nasopharyngeal flora in the first three years of life in normal and otitis-prone children. Ann Otol Rhinol Laryngol 1991, 100:612–615.
7. Harabuchi Y, Faden H, Yamanaka N, et al.: Human milk secretory IgA antibody to non-typable Haemophilus influenzae: possible protective effects against nasopharyngeal colonization. J Pediatr 1994, 124:193–198.
8. Miyamoto N, Bakaletz LO: Kinetics of ascension of NTHI from the nasopharynx to the middle ear coincident with adenovirus-induced compromise in the chinchilla. Microb Pathog 1997, 23:119–126. DOI: 10.1006/mpat.1997.0140
9. Bernstein JM, Dryja D, Yuskiw N, Murphy TF: Analysis of isolytes recovered from multiple sites of the nasopharynx of children colonized by non-typable Haemophilus influenzae. Eur J Clin Microbiol Infect Dis 1997, 16:750–753. DOI: 10.1007/BF01709258
10. Lim D, Hussl B: Tympanic mucosa after tube obstruction. Arch Otolaryngol Head Neck Surg 1970, 91:585–593.
11. Brandtzaeg P: Regionalized immune function of tonsils and adenoids. Immunol Today 1999, 20:383–384. Mucosal immunity is an important arm of the immune system because it operates in tissues involved in everyday infectious defense as well as intolerance against innocuous environmental and dietary antigens. In this article, Per Brandtzaeg and colleagues discuss compartmentalized regulation of B cells in the tonsils and adenoids that might explain the strikingly regionalized effector disparity of the human mucosal immune system. DOI: 10.1016/S0167-5699(99)01498-X
12. Bernstein JM: New perspectives on immunologic reactivity in otitis media with effusion. Ann Otol Rhinol Laryngol Suppl 1988, 132:19–23.
13. Brandtzaeg P, Baekkevold ES, Farstad IN, et al.: Regional specialization in the mucosal immune system: what happens in the micro-compartments? Immunol Today 1999, 20:141–151. According to the current paradigm of lymphocyte trafficking, primed B and T cells extravasate in the intestinal lamina propria chiefly by means of the mucosal homing receptor alpha-4 beta-7, which interacts with the vascular addressin MAdCAM-1. However, as discussed in this article, this mechanism cannot explain the preferential homing of B cells with a high level of J-chain expression to mucosal effector sites outside the gut. DOI: 10.1016/S0167-5699(98)01413-3
14. Bernstein JM, Scheeren R, Schoenfeld E, Albini B: The distribution of immunocompetent cells in the compartments of the palatine tonsils in bacterial and viral infections of the upper respiratory tract. Acta Otolaryngol Suppl 1988, 454:153–162.
15. Kurono Y, Shimamura K, Mogi G: The effect of mucosal and systemic immunization on nasopharyngeal colonization by non-typable Haemophilus influenzae in BALB/c mice. In Recent Advances in Otitis Media. Edited by Mogi G, Honjo I, Ishii T, Takasaka T. New York: Kugler Publications; 1994:479–483.
16. Ogra PL, Bernstein JM, Yurchak AM, et al.: Characteristics of secretory immune system in human middle ear: implications in otitis media. J Immunol 1974, 112:488–495.
17. Nadal D, Albini B, Chen CY, et al.: Distribution and engraftment patterns of human tonsillary mononuclear cells and immunoglobulin-secreting cells in mice with severe combined immunodeficiency: role of the Epstein-Barr virus. Int Arch Allergy Immunol 1991, 95:341–351. DOI: 10.1159/000235471
18. Ryan AF, Sharp PA, Harris JP: Homing of mucosal and non-mucosal lymphocytes to the tympanic cavity from the Eustachian tube, clinical aspects. Edited by Sade J. New York: Kugler Publications; 1991:33–37.
19. Ogra PL, Giebink GS, Barenkamp SJ, et al.: Recent advances in otitis media. Microbiology, bdImmunology, Biochemistry, and Vaccination [review]. Ann Otol Rhinol Laryngol Suppl 1989, 139:23–32.
20. Bernstein JM, Faden HS, Loos BG, et al.: Recurrent otitis media with non-typable Haemophilus influenzae: the role of serum bactericidal antibody. Int J Pediatr Otorhinolaryngol 1992, 23:1–13. DOI: 10.1016/0165-5876(92)90074-Y
21. Bernstein JM, Bronson P, Hamilton RG, Wilson ME: IgG subclass responses to purified outer membrane proteins (OMP) and lipo-oligosaccharides (LOS) of non-typable Haemophilus influenzae (NTHI) in a child with recurrent otitis media. In Recent Advances in Otitis Media. Edited by Mogi G, Honjo I, Ishii T, Takasaka T. New York: Kugler Publications; 1994:513–528.
22. Bernstein JM, Bronson PM, Wilson ME: Immunoglobulin G subclass response to major outer membrane proteins of non-typable Haemophilus influenzae in children with acute otitis media. Otolaryngol Head Neck Surg 1997, 116:363–371. DOI: 10.1016/S0194-5998(97)70275-4
23. Faden H, Krystofik DA, Hong JJ, et al.: Immune response to non-typable Haemophilus Influenzae in the general population and among children with otitis media with effusion. Ann Otol Rhinol Laryngol Suppl 1988, 132:34–36.
24. Kurono Y, Shimamura K, Shigemi H, Mogi G: Inhibition of bacterial adherence by nasopharyngeal secretions. Ann Otol Rhinol Laryngol 1991, 100:455–458.
25. Mauel J: Macrophage activation by OM-85BV. Respiration 1992, 59(suppl):14–18.
26. Bakaletz LO, Leake ER, Billy JM, Kaumaya PT: Relative immunogenicity and efficacy of two synthetic chimeric peptides of fimbrim as vaccinogens against nasopharyngeal colonization by non-typable Haemophilus influenzae in the chinchilla. Vaccine 1997, 15:955–961. DOI: 10.1016/S0264-410X(96)00298-8
27. Eden CS, Freter R, Hagberg L, et al.: Inhibition of experimental ascending urinary tract infection by an epithelial cell-surface receptor analogue. Nature 1982, 298:560–562. DOI: 10.1038/298560a0
28. Roos K, Hakansson EG, Holm S: Effect of recolonization with “interfering” alpha Streptococci on recurrences of acute and secretory otitis media in children: randomized placebocontrolled study. BMJ 2001, 322:210–212. DOI: 10.1136/bmj.322.7280.210
29. Roos K, Holm SE, Grahn-Hakansson E, Lagergren L: Recolonization with selected alpha-Streptococci for prophylaxis of recurrent streptococcal pharyngo tonsillitis - a randomized placebo-controlled multi-center study. J Infect Dis 1996, 28:459–462. DOI: 10.3109/00365549609037940
30. Klein JO, Chonmaitree T, Loosmore S, et al.: Otitis media: a preventable disease? Proceedings of an International Symposium Organized by the Marcel Merieux Foundation. Pediatr Infect Dis J 2001, 20:473–481. This review includes topics involving pathogenesis of otitis media, prevention of respiratory viral infections, immunization against bacterial etiologies of otitis media and non-vaccine prophylaxis of otitis media. The authors have edited and selected materials of interest from the presentations and discussions of a conference held in France in December 2000.